FRT is typically administered intravenously. The dosage and frequency depend on the specific clotting factor deficiency, the severity of the condition, and the clinical scenario. For instance, women with von Willebrand disease may receive desmopressin or von Willebrand factor concentrates, while hemophilia carriers may need specific factor VIII or IX concentrates.
